title: Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors.
authors: Fifth Medical Department with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria.
authors: K
authors: K
authors: Geissler
authors: Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
authors: E
authors: E
authors: Jäger
authors: Blood Transfusion Service for Upper Austria, Austrian Red Cross, Linz, Austria.
authors: A
authors: A
authors: Barna
authors: Fifth Medical Department with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria.
authors: T
authors: T
authors: Alendar
authors: Fifth Medical Department with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria.
authors: E
authors: E
authors: Ljubuncic
authors: Third Medical Department, Hanusch Hospital, Vienna, Austria.
authors: T
authors: T
authors: Sliwa
authors: Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
authors: P
authors: P
authors: Valent
mesh_terms: D006801:Humans; D066298:In Vitro Techniques; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology; D015477:Leukemia, Myelomonocytic, Chronic / Q000235:genetics* / Q000473:pathology; D009154:Mutation; D015689:Oncogene Protein p21(ras) / Q000235:genetics*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D015689:Oncogene Protein p21(ras)